Loading...

Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5

OBJECTIVE: The obesity epidemic is a public health concern, warranting further research into pharmacological treatments for weight management (WM) as an adjunct to lifestyle interventions. The Semaglutide Treatment Effect in People with obesity (STEP) program aims to investigate the effect of semagl...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Obesity (Silver Spring)
Main Authors: Kushner, Robert F., Calanna, Salvatore, Davies, Melanie, Dicker, Dror, Garvey, W. Timothy, Goldman, Bryan, Lingvay, Ildiko, Thomsen, Mette, Wadden, Thomas A., Wharton, Sean, Wilding, John P.H., Rubino, Domenica
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley and Sons Inc. 2020
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318657/
https://ncbi.nlm.nih.gov/pubmed/32441473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/oby.22794
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!